BiotechTube
Home/MediMabBio/Hongseok Jo, Ph.D.
HJ

Hongseok Jo, Ph.D.

Founder & Co-CEO

MediMabBio

Therapeutic Areas

OncologyAutoimmune Diseases

MediMabBio Pipeline

DrugIndicationPhase
aTIGIT-IL15 Fusion AntibodyOncologyPre-clinical

Leadership Team at MediMabBio

JY
Jennifer Yuhoi Kang, D.Phil.
Founder & Co-CEO
JL
Ji-Eun Lee, Ph.D.
CEO of MediMab Biotherapeutics
EK
Eunok Kang
COO
EC
Eunhyuk Chang, D.Phil.
CSO (Chief Strategy Officer)
KK
Kwanghyun Kim
CFO
EK
Eunjoo Kim
CDO
View full MediMabBio profile